Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Interpretation of Laboratory Tests: A Case-Oriented Review of Clinical Laboratory Diagnosis Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health Science Center/Jacksonville 1 Case 1: Oliguria and hematuria 2 Case 1: Oliguria and hematuria A 7-year-old boy was brought to the pediatrician because of vomiting and malaise. On physical examination he was slightly flushed, and had some noticeable swelling of his hands and feet. The patient was uncomfortable, and complained of pain “in his tummy”. He had a slight fever. Heart was normal and lungs were clear. His past medical history did not include any chronic diseases. The mother noted that he had a severe sore throat “about two weeks ago”, but that it had cleared up on its own. The child was not taking any medications. There were no masses in the abdomen, and lymphadenopathy was not present. The child had some difficulty producing a urine specimen, but finally was able to produce a small amount of urine, which was dipstick-positive for blood and protein. R. Bertholf American Society of Clinical Pathologists 3 Questions. . . • What is the differential diagnosis in this case? • What laboratory tests might be helpful in establishing the diagnosis? R. Bertholf American Society of Clinical Pathologists 4 What do the kidneys do? • • • • • Regulate body fluid osmolality and volume Regulate electrolyte balance Regulate acid-base balance Excrete metabolic products and foreign substances Produce and excrete hormones R. Bertholf American Society of Clinical Pathologists 5 The kidneys as regulatory organs “The kidney presents in the highest degree the phenomenon of sensibility, the power of reacting to various stimuli in a direction which is appropriate for the survival of the organism; a power of adaptation which almost gives one the idea that its component parts must be endowed with intelligence.” E. Starling (1909) R. Bertholf American Society of Clinical Pathologists 6 Review of Renal Anatomy and Physiology • The kidneys are a pair of fist-sized organs that are located on either side of the spinal column just behind the lower abdomen (L1-3). • A kidney consists of an outer layer (renal cortex) and an inner region (renal medulla). • The functional unit of the kidney is the nephron; each kidney has approximately 106 nephrons. R. Bertholf American Society of Clinical Pathologists 7 Renal anatomy Cortex Pelvis Capsule Medulla To the bladder R. Bertholf American Society of Clinical Pathologists 8 The Nephron Proximal tubule Afferent arteriole Distal tubule Glomerulus Bowman’s capsule Collecting duct Renal artery Henle’s Loop R. Bertholf American Society of Clinical Pathologists 9 Glomerular filtration Vascular space Glomerlular capillary membrane Bowman’s space Mean capillary blood pressure = 50 mm Hg 2,000 Liters per day 200 Liters per day BC pressure = 10 mm Hg (25% of cardiac output) Onc. pressure = 30 mm Hg Net hydrostatic = 10 mm Hg R. Bertholf GFR 130 mL/min American Society of Clinical Pathologists 10 What gets filtered in the glomerulus? • Freely filtered • Some filtered • None filtered – H2O – Immunoglobulins – 2-microglobulin – Na+, K+, Cl-, – RBP – Ferritin HCO3-, Ca++, – Cells – 1-microglobulin Mg+, PO4, etc. – Albumin – Glucose – Urea – Creatinine – Insulin R. Bertholf American Society of Clinical Pathologists 11 Then what happens? • If 200 liters of filtrate enter the nephrons each day, but only 1-2 liters of urine result, then obviously most of the filtrate (99+ %) is reabsorbed. • Reabsorption can be active or passive, and occurs in virtually all segments of the nephron. R. Bertholf American Society of Clinical Pathologists 12 Reabsorption from glomerular filtrate % Reabsorbed Water Sodium Potassium Chloride Bicarbonate Glucose Albumin Urea Creatinine R. Bertholf 99.2 99.6 92.9 99.5 99.9 100 95-99 50-60 0 (or negative) American Society of Clinical Pathologists 13 How does water get reabsorbed? • Reabsorption of water is passive, in response to osmotic gradients and renal tubular permeability. – The osmotic gradient is generated primarily by active sodium transport – The permeability of renal tubules is under the control of the renin-angiotensin-aldosterone system. • The driving force for water reabsorption, the osmotic gradient, is generated by the Loop of Henle. R. Bertholf American Society of Clinical Pathologists 14 The Loop of Henle Proximal tubule Distal tubule Na+ Ascending loop H 2O Descending loop Increasing osmolality Renal Cortex 300 mOsm/Kg Na+ Na+ Na+ Renal Medulla 1200 mOsm/Kg R. Bertholf American Society of Clinical Pathologists 15 Regulation of distal tubule Na+ permeability JGA Na+ BP Renin Angiotensinogen Angiotensin I Angiotensin II vasoconstriction Angiotensin III Aldosterone Adrenal cortex Na+ R. Bertholf American Society of Clinical Pathologists Na+ 16 Regulation of H2O reabsorption Pituitary Plasma hyperosmolality ADH (vasopressin) H2O H2O Renal Medulla (osmolality 1200 mOsm/Kg) R. Bertholf American Society of Clinical Pathologists 17 Summary of renal physiology TRPF (Filtered and secreted) Filtration - Reabsorption + Secretion = Elimination GFR (Filtered but not reabsorbed or secreted) R. Bertholf American Society of Clinical Pathologists 18 Measurement of GFR Cu Vu ( 24h ) Clearance 0.694 C p Cu = Concentration in urine Vu(24h) = 24-hour urine volume Cp = Concentration in plasma 0.694 = 1000 mL/1440 min R. Bertholf American Society of Clinical Pathologists 19 Compounds used to measure GFR • Should not be metabolized, or alter GFR • Should be freely filtered in the glomeruli, but neither reabsorbed nor secreted • Inulin (a polysaccharide) is ideal • Creatinine is most popular – There is some exchange of creatinine in the tubules – As a result, creatinine clearance overestimates GFR by about 10% (But. . .) • Urea can be used, but about 40% is (passively) reabsorbed R. Bertholf American Society of Clinical Pathologists 20 Relationship between creatinine and GFR Plasma creatinine 6 5 4 3 2 1 0 0 R. Bertholf 20 40 60 80 100 GFR (mL/min) American Society of Clinical Pathologists 120 140 21 Measurement of TRPF • Para-aminohippurate (PAH) is freely filtered in the glomeruli and actively secreted in the tubules. • PAH clearance gives an estimate of the total amount of plasma from which a constituent can be removed. R. Bertholf American Society of Clinical Pathologists 22 Creatinine Creatine Creatinine 1-2% of creatine is hydrolyzed to creatinine each day R. Bertholf American Society of Clinical Pathologists 23 Jaffe method for creatinine Janovsky Complex max = 490-500 nm Max Eduard Jaffe (1841-1911), German physiologic chemist R. Bertholf American Society of Clinical Pathologists 24 Modifications of the Jaffe method • Fuller’s Earth (aluminum silicate, Lloyd’s reagent) – adsorbs creatinine to eliminate protein interference • Acid blanking – after color development; dissociates Janovsky complex • Pre-oxidation – addition of ferricyanide oxidizes bilirubin • Kinetic methods R. Bertholf American Society of Clinical Pathologists 25 0 R. Bertholf A t Slow-reacting (protein) A rate t Fast-reacting (pyruvate, glucose, ascorbate) Absorbance ( = 520 nm) Kinetic Jaffe method creatinine (and -keto acids) 20 Time (sec) American Society of Clinical Pathologists 80 26 Enzymatic creatinine methods • Creatininase – creatininecreatineCKADPPKLD • Creatinase – creatininecreatinesarcosinesarcosine oxidaseperoxideperoxidase reaction • Creatinine deaminase (iminohydrolase) – most common R. Bertholf American Society of Clinical Pathologists 27 Creatinine deaminase method Creatinine Sarcosine Creatinine iminohydrolase + H2O NCS amidohydrolase - NH3, CO2 Sarcosine oxidase N-Methylhydantoin ATP NMH amidohydrolase N-Carbamoylsarcosine ADP Formaldehyde + glycine + O2 H2O H2O2 Oxygen receptor R. Bertholf H2O Peroxidase Colored product American Society of Clinical Pathologists 28 Measurement of urine protein • Specimen – Timed 24-h is best – Urine protein/creatinine ratio can be used with random specimen • Normal protein excretion is <150 mg/24h – 50-60% albumin – Smaller proteins (1-, 2-microglobulins) – Tamm-Horsfall (uromucoid, secreted by tubules) – IgA, tubular epithelial enzymes, and other nonfiltered components R. Bertholf American Society of Clinical Pathologists 29 Dipstick method for urine protein • Method is based on protein association with pH indicator • Test pad contains dye tetrabromphenol blue at pH=3 • If protein binds to the pH indicator, H+ is displaced and the color changes from yellow to green (or blue) • Most sensitive to albumin (poor method for detecting tubular proteinuria) R. Bertholf American Society of Clinical Pathologists 30 What causes excess urinary protein? • Overload proteinuria – Bence-Jones (multiple myeloma) – Myoglobin (crush injury, rhabdomyolysis) – Hemoglobin • Tubular proteinuria – Mostly low MW proteins (not albumin) – Fanconi’s, Wilson’s, pyelonephritis, cystinosis • Glomerular proteinuria – Mostly albumin at first, but larger proteins appear as glomerular membrane selectivity is lost. R. Bertholf American Society of Clinical Pathologists 31 Classification of proteinuria: Minimal • • • • • <1 gram of protein per day Chronic pyelonephritis Mild glomerular disease Nephrosclerosis (usually due to hypertension) Chronic interstitial nephritis (usually analgesicrelated) • Renal tubular disease R. Bertholf American Society of Clinical Pathologists 32 Classification of proteinuria: Moderate • • • • 1.0 - 4.0 grams of protein per day Usually associated with glomerular disease Overflow proteinuria from multiple myeloma Toxic nephropathies R. Bertholf American Society of Clinical Pathologists 33 Classification of proteinuria: Severe • >4 grams of protein per day • Nephrotic syndrome (GBM permeability) – Sx: edema, proteinuria, hypoalbuminemia, hyperlipidemia – In adults, usually 2 to systemic disease (SLE, diabetes) – In children, cause is usually primary renal disease • Minimal Change Disease (Lipoid Nephrosis) – Most common cause of NS in children – Relatively benign (cause unknown, not autoimmune) R. Bertholf American Society of Clinical Pathologists 34 Proteinuria due to glomerulonephritis • Acute, rapidly progressive, or chronic GN can result in severe proteinuria • Often the result of immune reaction (Circulating Immune-Complex Nephritis) – Antigen can be endogenous (SLE) or exogeneous – Glomerular damage is mostly complementmediated – If antigen is continuously presented, GN can become chronic R. Bertholf American Society of Clinical Pathologists 35 How do red blood cells get in urine? • Hematuria can result from bleeding anywhere in the kidneys or urinary tract – Disease, trauma, toxicity • Hemoglobinuria can result from intravascular hemolysis – Disease, trauma, toxicity R. Bertholf American Society of Clinical Pathologists 36 Dipstick method for hemoglobin Heme H2O2 + chromogen* Peroxidase Oxidized chromogen + H2O • Ascorbic acid inhibits the reaction, causing a false negative test • Depends on RBC lysis (may not occur in urine with high specific gravity) • Detection limit approximately 10 RBC/L *tetramethylbenzidine; oxidized form is green R. Bertholf American Society of Clinical Pathologists 37 Microscopic examination of urine sediment R. Bertholf American Society of Clinical Pathologists 38 Significance of RBC casts in urine • • • • Indicative of blood crossing the GBM Casts form in the distal tubules Stasis produces brown, granular casts RBC casts almost always reflect glomerular disease R. Bertholf American Society of Clinical Pathologists 39 Bright’s Disease (acute glomerulonephritis) • Characterized by oliguria, proteinuria, and hematuria • Most common cause is immune-related Richard Bright (1789-1858) R. Bertholf American Society of Clinical Pathologists 40 Primary Glomerulonephritis • Proliferative GN – Acute Post-infectious GN – Idiopathic or Crescentic GN – -GBM disease – Membranoproliferative GN • Focal GN – IgA nephropathy R. Bertholf American Society of Clinical Pathologists 41 Primary Glomerulonephritis, cont. • Idiopathic membranous GN – Histological diagnosis, probably immune complex • Chronic GN – Clinical Dx; many potential causes • Lipoid Nephrosis – Histological findings normal; “Nephrosis” • Focal Glomerular Sclerosis – Probably immune (IgM) related R. Bertholf American Society of Clinical Pathologists 42 Secondary Glomerulonephritis • Systemic Lupus Erythematosus – Renal failure accounts for 50% of SLE deaths • Polyarteritis (inflammatory vasculitis) • Wegener’s Granulomatosis (lung and URT) • Henoch-Schönlein Syndrome – Lacks edema assoc. with post-streptococcal GN • Goodpasture’s Syndrome (pulmonary hemorrhage) • Hemolytic-Uremic Syndrome • Progressive Systemic Sclerosis (blood vessels) R. Bertholf American Society of Clinical Pathologists 43 Case 3: Chest Pain 44 Case 3: Chest Pain A 63 year old male was brought to the emergency department after complaining of severe chest pain that had lasted for two hours. He had been mowing his lawn when the pain developed, and he became concerned when the pain did not subside after he stopped the activity. He had no previous history of heart disease. On presentation he was moderately overweight, diaphoretic, and in obvious discomfort. He described his chest pain as “beginning in the center of my chest, then my arms, neck, and jaw began to ache too.” Diagnostic procedures were performed. R. Bertholf American Society of Clinical Pathologists 45 Questions • What is the most important consideration in the triage of this patient? • What tests should be ordered? R. Bertholf American Society of Clinical Pathologists 46 Chest pain • One of the most common reasons for seeking medical attention • Characteristics of cardiogenic chest pain (angina) – induced by exercise – described as “pressure” – radiates to extremities – MI not relieved by rest or vasodilatory drugs (NG) • Only 25% of patients presenting with chest pain as the primary complaint will ultimately be diagnosed as MI (specificity=25%; sensitivity=80%) R. Bertholf American Society of Clinical Pathologists 47 The Heart Aorta Pulmonary arteries Superior vena cava LA RA LV RV R. Bertholf American Society of Clinical Pathologists 48 The Heart (posterior view) Aorta Superior vena cava Pulmonary arteries Pulmonary veins Inferior vena cava R. Bertholf American Society of Clinical Pathologists 49 Cardiac physiology R. Bertholf American Society of Clinical Pathologists 50 Cardiac conduction system Sinoatrial (SA) node Atrioventral (AV) node His bundle Left bundle branch Right bundle branch R. Bertholf American Society of Clinical Pathologists 51 Normal Electrocardiogram R T U P Q S R. Bertholf American Society of Clinical Pathologists 52 Myocardial infarction Left coronary artery Anterior left ventricle Right coronary artery R. Bertholf American Society of Clinical Pathologists 53 ECG changes in myocardial infarction R S-T elevation T P Q S R. Bertholf American Society of Clinical Pathologists 54 Diagnostic value of ECG • ECG changes depend on the location and severity of myocardial necrosis • Virtually 100% of patients with characteristic Qwave and S-T segment changes are diagnosed with myocardial infarction (100% specificity) • However, as many as 50% of myocardial infarctions do not produce characteristic ECG changes (sensitivity 50%) • ECG may be insensitive for detecting prognostically significant ischemia R. Bertholf American Society of Clinical Pathologists 55 History of cardiac markers • 1975: Galen describes the use of CK, LD, and isoenzymes in the diagnosis of myocardial infarction. • 1980: Automated methods for CK-MB (activity) and LD-1 become available. • 1985: CK-MB isoforms are introduced. • 1989: Heterogeneous immunoassays for CK-MB (mass) become available. • 1991: Troponin T immunoassay is introduced. • 1992: Troponin I immunoassay is introduced. R. Bertholf American Society of Clinical Pathologists 56 Enzyme markers • Aspartate transaminase (AST; SGOT) • 2-Hydroxybutyrate dehydrogenase • Lactate dehydrogenase – Five isoenzymes, composed of combinations of H (heart) and M (muscle) subunits • Creatine kinase – Three isoenzymes, composed of combinations of M (muscle) and B (brain) subunits R. Bertholf American Society of Clinical Pathologists 57 Lactate dehydrogenase (LD) NAD+ NADH Pyruvate LD Lactate • LD activity is measured by monitoring absorbance at = 340 nm (NADH) • Methods can be P L or L P – But. . .reference range is different • Total LD activity has poor specificity R. Bertholf American Society of Clinical Pathologists 58 Tissue specificity of LD isoenzymes LD isoenzyme Tissues LD-1 Heart (60%), RBC, Kidney LD-2 Heart (30%), RBC, Kidney LD-3 Brain, Kidney LD-4 Liver, Skeletal muscle, Brain, Kidney LD-5 Liver, Skeletal muscle, Kidney R. Bertholf American Society of Clinical Pathologists 59 LD isoenzyme electrophoresis (normal) LD-2 > LD-1 > LD-3 > LD-4 > LD-5 LD-2 LD-1 LD-3 LD-4 LD-5 Cathode (-) R. Bertholf Anode (+) American Society of Clinical Pathologists 60 LD isoenzyme electrophoresis (abnormal) LD-1 LD-1 > LD-2 LD-2 LD-3 LD-4 LD-5 Cathode (-) R. Bertholf Anode (+) American Society of Clinical Pathologists 61 Direct measurement of LD-1 • Electrophoresis is time-consuming and only semiquantitative • Antibodies to the M subunit can be used to precipitate LD-2, 3, 5, and 5, leaving only LD-1 – Method can be automated – Normal LD-1/LDtotal ratio is less than 40% R. Bertholf American Society of Clinical Pathologists 62 Sensitivity and specificity of LD-1 • Sensitivity and specificity of the LD 1:2 “flip”, or LD-1 > 40% of total, are 90+% within 24 hours of MI, but. . . – May be normal for 12 or more hours after symptoms appear (peak in 72-144 hours) – May not detect minor infarctions • Elevations persist for up to 10 days • Even slight hemolysis can cause non-diagnostic elevations in LD-1 R. Bertholf American Society of Clinical Pathologists 63 Creatine Kinase (CK) Phosphocreatine ADP CK Creatine Mg++ ATP Glucose ADP HK Glucose-6-phosphate NADP+ GPD 6-Phosphogluconate NADPH =340 nm Oliver and Rosalki method (1967) R. Bertholf American Society of Clinical Pathologists 64 Tissue specificities of CK isoenzymes CK-1 (BB) CK-2 (MB) CK-3 (MM) Skeletal muscle 0% 1% 99% Cardiac muscle 1% 20% 79% Brain 97% 3% 0% Tissue R. Bertholf American Society of Clinical Pathologists 65 Measurement of CK isoenzymes • Electrophoresis (not used anymore) • Immunoinhibition/precipitation – Antibody to M subunit – Multiply results by 2 – Interference from CK-1 (BB) • Most modern methods use two-site (“sandwich”) heterogeneous immunoassay – Measures CK-MB mass, rather than activity – Gives rise to a pseudo-percentage, often called the “CK-MB index” R. Bertholf American Society of Clinical Pathologists 66 Sensitivity/specificity of CK-MB • Sensitivity and specificity of CK-MB for myocardial infarction are >90% within 7-18 hours; peak concentrations occur within 24 hours • CK is a relatively small enzyme (MW = 86K), so it is filtered and cleared by the kidneys; levels return to normal after 2-3 days • Sensitivity is poor when total CK is very high, and specificity is poor when total CK is low • Presence of macro-CK results in false elevations R. Bertholf American Society of Clinical Pathologists 67 CK isoforms C-terminal lysine CK-MB2 (tissue) Plasma carboxypeptidase CK-MB1 (circulating) • C-terminal lysine is removed from the M subunit-therefore, there are three isoforms of CK-3 (MM) • t½: CK-MB1 > CK-MB2 • Ratio of CK-MB2 to CK-MB1 exceeds 1.5 within six hours of the onset of symptoms • Only method currently available is electrophoresis R. Bertholf American Society of Clinical Pathologists 68 Myoglobin • O2-binding cytosolic protein found in all muscle tissue (functional and structural analog of hemoglobin) • Low molecular weight (17,800 daltons) • Elevations detected within 1-4 hours after symptoms; returns to normal after 12 hours • Nonspecific but sensitive marker--primarily used for negative predictive value • Usually measured by sandwich, nephelometric, turbidimetric, or fluorescence immunoassay R. Bertholf American Society of Clinical Pathologists 69 Temporal changes in myoglobin and CK-MB CK-MB 800 60 50 40 30 20 10 0 600 400 200 0 0 8 16 24 32 40 CK-MB (ug/L) Myoglobin (ug/L) Myoglobin 48 Time after symptoms R. Bertholf American Society of Clinical Pathologists 70 Troponin Tropomyosin Actin TnT (42 Kd) TnI (23 Kd) TnC Myosin Thick Filament R. Bertholf American Society of Clinical Pathologists 71 Tissue specificity of Troponin subunits • Troponin C is the same in all muscle tissue • Troponins I and T have cardiac-specific forms, cTnI and cTnT • Circulating concentrations of cTnI and cTnT are very low • cTnI and cTnT remain elevated for several days • Hence, Troponins would seem to have the specificity of CK-MB (or better), and the long-term sensitivity of LD-1 R. Bertholf American Society of Clinical Pathologists 72 Is cTnI more sensitive than CK/CK-MB? 79 y/o female with Hx of HTN, CHF, CRI, Type II diabetes log X normal 1 0.5 CK CK-MB CK-MB Index cTnI 0 -0.5 -1 1 8 40 66 Hours since presentation R. Bertholf American Society of Clinical Pathologists 73 Measurement of cTnI and cTnT • All methods are immunochemical (ELISA, MEIA, CIA, ECIA) • Roche Diagnostics (formerly BMC) is the sole manufacturer of cTnT assays – First generation assay may have had some crossreactivity with skeletal muscle TnT – Second generation assay is cTnT-specific – Also available in qualitative POC method • Many diagnostics companies have cTnI methods R. Bertholf American Society of Clinical Pathologists 74 W.H.O. has a Myocardial Infarction? A patient presenting with any two of the following: • A clinical history of ischemic-type chest discomfort • Changes on serially obtained ECG tracings • A rise and fall in serum cardiac markers Source JACC 28;1996:1328-428 R. Bertholf American Society of Clinical Pathologists 75 Sensitivity/Specificity of WHO Criteria 100% 80% 60% Sensitivity Specificity 40% 20% 0% Chest Pain ECG changes R. Bertholf Serum markers American Society of Clinical Pathologists 76 # of labs reporting What Cardiac Markers do Labs Offer? 3500 3000 2500 2000 1500 1000 500 0 1997 1998 CK-MB (ng/mL) R. Bertholf CK-MB (IU/L) cTnI cTnT American Society of Clinical Pathologists 77